V. Misra et al., Assessment of the relationship between genotypic status of a DT-diaphorasepoint mutation and enzymatic activity, BR J CANC, 83(8), 2000, pp. 998-1002
DT-diaphorase, a cytosolic reductase, has been implicated as an activator o
f chemotherapeutic prodrugs and a detoxifier of certain potentially carcino
genic xenobiotics. A common C to T nucleotide 609 substitution in DT-diapho
rase cDNA has been associated with protein instability and reduced catalyti
c activity. The degree to which the allelic status of the substitution corr
elates with enzymatic activity was assessed in 45 normal human skin fibrobl
ast strains using a PCR-RFLP assay. Included in this study was the 3437T st
rain, which is unique in that it is heterozygous for the polymorphism yet c
ontains undetectable enzymatic activity. An allele-specific RT-PCR-RFLP tec
hnique attributed this phenomenon to exclusive DT-diaphorase mRNA expressio
n from the variant allele. Overlap in activities was observed between indiv
idual strains homozygous for the wild-type allele and heterozygotes, but th
e former group displayed enzymatic activity that was on average 2-fold high
er. Western blot analysis of the two strains in this panel that are homozyg
ous for the Variant allele revealed that they express relatively low amount
s of DT-diaphorase protein, consistent with the role of the substitution in
protein instability This work confirms that genotypic status is a reliable
initial estimate of DT-diaphorase activity. (C) 2000 Cancer Research Campa
ign.